| Status | Study |
| Recruiting |
Study Name: Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage Condition: Ovarian Cancer Ovarian Carcinoma Fallopian Tube Cancer Date: 2017-05-03 Interventions: Procedure: Uterine lavage Uter |
| Recruiting |
Study Name: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Condition: Acinar Cell Carcinoma Adrenal Cortex Carcinoma Adrenal Gla Date: 2016-07-13 Interventions: Procedure: Biospecimen Collection |
| Not yet recruiting |
Study Name: Proof-of-concept Study of Birinapant in Combination With Platinum Based Chemotherapy in Subjects With High Grade Serous Carcinomas Condition: Advanced Newly Diagnosed or Recurrent High Grade Serous Carcinomas (HGSC) Date: 2016-04-22 Interventions: Drug: Birinapant Birinapant - |
| Recruiting |
Study Name: A Phase II Evaluation of Afatinibin Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma Condition: HER2/Neu+ Uterine Serous Carcinoma Date: 2015-07-02 Interventions: Drug: Afatinib Afatinib, 40 mg orally once daily on a 21 day cycle for the first 12 weeks, then every 28 |
| Recruiting |
Study Name: Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis Condition: Cancer Date: 2015-04-14 Interventions: Drug: systemic chemotherapy twelve months of 5-FU or capecitabine with bevacizumab starting 4-8 weeks af |
| Active, not recruiting |
Study Name: Phase I/IIA Study MK-3475 With Chemotherapy in Patients With Advanced GI Cancers Condition: Advanced GI Cancer Date: 2014-10-15 Interventions: Drug: MK-3475 MK-3475 in combination with mFOLFOX6 in a 14 |
| Recruiting |
Study Name: Non Ivasive Prenatal Diagnosis (NIPD) of Cystic Fibrosis Condition: Noninvasive Mucinous Cystadenocarcinoma of Ovary Date: 2014-04-22 Interventions: Other: A sampling of blood A sampling of blood de 14 ml |
| Recruiting |
Study Name: Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Condition: Ovarian Brenner Tumor Ovarian Carcinosarcoma Ovarian Clear Date: 2014-03-28 Interventions: Drug: Gemcitabine Hydrochloride |
| Recruiting |
Study Name: Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei Condition: Gastrointestinal Neoplasms Date: 2013-09-12 Interventions: Behavioral: Questionnaire Completion of 3 questionnaires a |
| Active, not recruiting |
Study Name: Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer Condition: Mucinous Adenocarcinoma of the Colon Muci Date: 2012-07-25 Interventions: Biological: aflibercept 4 mg/k |